NCT00973752 - Treatment of Older Adults With Acute Lymphoblastic Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2014

Study Completion Date

April 30, 2016

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG

Prednisone

Orally during Induction, Consolidation 1, CNS, Consolidation 2, and Continuation therapy.

DRUG

Vincristine

Intravenously during Induction, CNS, Consolidation 2 and Continuation Therapy

DRUG

Doxorubicin

Intravenously during Induction, CNS, and Consolidation 2 therapy

DRUG

PEG-asparaginase

Intravenously during Induction, Consolidation 1, CNS, and Consolidation 2 therapy

DRUG

Cytarabine

Intrathecally during Induction and CNS therapy

DRUG

Methotrexate

Intrathecally during Induction, CNS, and Continuation Therapy

DRUG

Imatinib

Orally during Induction, Consolidation 1, CNS, Consolidation 2 and Continuation Therapy

DRUG

Clofarabine

Intravenously during Consolidation 1 Therapy

DRUG

6 Mercaptopurine

Orally during CNS, Consolidation 2 and Continuation Therapy

Trial Locations (3)

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston